Chen, T. C. et al. Genetic characteristics and epidemiology of inherited retinal degeneration in Taiwan. NPJ Genom Med. 6, 16. https://doi.org/10.1038/s41525-021-00180-1 (2021).
Cornelis, S. S….
Chen, T. C. et al. Genetic characteristics and epidemiology of inherited retinal degeneration in Taiwan. NPJ Genom Med. 6, 16. https://doi.org/10.1038/s41525-021-00180-1 (2021).
Cornelis, S. S….

Elon Musk’s X has begun rolling out a new feature for user profiles that will display information about the account, including where it’s based, how many times the account has changed its username, the account’s original join date, and how…

Digital interventions have the potential to improve health care delivery by improving effectiveness, accessibility, the ability to reach patients, cost-effectiveness, and personalization [-]. The prevalent use of digital…

Over 1,642,106 person-years of follow-up, 19,140 MACE events occurred (incidence rate 11.66 per 1000 person-years; 95% CI: 11.49–11.82) (Supplementary Table S6 and Table S7). In the MACE analysis, the…

Google Pixel deals abound! The company has kicked off its Black Friday promotions on all of its Pixel hardware, from the value-friendly Pixel 9a to the flagship Pixel 10 Pro XL. There are even discounts on the brand-new Pixel Watch 4 and Google’s…

USA Gymnastics announced Monday (17 November) the return of the American Cup competition to the gymnastics calendar. The event, first held in 1976 when Nadia Comaneci took the…

Item 1 of 3 Cannabis buds used to extract medicinal CBD oil are placed in a beaker as Kiara Cardoso, founder of DNA Solucoes em Biotecnologia, works, in Petrolina, Pernambuco, Brazil, February 7, 2025. REUTERS/Kira Duarte/File Photo
SAO PAULO, Nov 21 (Reuters) – Brazilian agricultural research agency Embrapa has received the greenlight from health agency Anvisa to research the cannabis plant, a landmark move that puts farming powerhouse Brazil a step closer towards authorizing its cultivation.
In an interview on Friday, Embrapa researcher Daniela Bittencourt welcomed Anvisa’s decision this week, which gives the agency unprecedented permission to build its first-ever cannabis seed bank and develop projects to genetically improve the plant for various applications.
Sign up here.
Embrapa will also research hemp used to produce fibers, Bittencourt said.
“This is only the beginning,” Bittencourt said by telephone from Brasilia. “Our plan is to carry out research for 12 years but it may possibly go on forever, like what happens with soy and corn.”
Similar research efforts from Embrapa since the 1970s opened up vast regions of Brazil for large-scale soybean farming, kicking off a significant increase in the country’s output of the oilseed to make it the world’s largest producer and exporter.
An initial 13 million reais ($2.41 million) in public funding will imminently be released to fund Embrapa’s cannabis research, Bittencourt said, adding the agency is open to studying the plant in partnership with the private sector.
In the decision authorizing Embrapa’s cannabis research, Anvisa said it is developing rules for growing cannabis “for medicinal and scientific purposes.”
($1 = 5.3926 reais)
(This story has been corrected to say that Embrapa applied for authorization to conduct cannabis research in September 2024, not February 2024, in paragraph 6)
Reporting by Ana Mano; Editing by Richard Chang
Our Standards: The Thomson Reuters Trust Principles.